List of Figures
Figure 1: Post Marketing Clinical Research, Safety Concept Through Clinical Research 10
Figure 2: Post Marketing Clinical Research, Limitations of Clinical Trials 11
Figure 3: Post Marketing Clinical Research, Assessment of Side Effects - Case Study 15
Figure 4: Post Marketing Clinical Research, Objectives of Post Marketing Clinical Research 20
Figure 5: Post Marketing Clinical Research, Components of Post Marketing Clinical Research 21
Figure 6: Post Marketing Clinical Research, Importance of REMS 23
Figure 7: Post Marketing Clinical Research, Perspective of Pharmacoeconomic Analysis 25
Figure 8: Post Marketing Clinical Research, Types of Pharmacoeconomic Research 26
Figure 9: Post Marketing Clinical Research, Epidemiology Study Designs 28
Figure 10: Post Marketing Clinical Research, Safety Signal Detection Methods 32
Figure 11: Post Marketing Clinical Research, Safety Signal Investigation and Evaluation 33
Figure 12: Post Marketing Clinical Research, Regulatory Provisions of Post Marketing Studies in Children 36
Figure 13: Post Marketing Clinical Research, Issues of Drug Safety in the Elderly - Case Study 39
Figure 14: Post Marketing Clinical Research, Drug Labeling and Pregnancy 41
Figure 15: Post Marketing Clinical Research, Issues of Drug Safety in Pregnant Women - Case Study 42
Figure 16: Post Marketing Clinical Research, Accelerated Approval of Oncology Drugs – Gleevec Case Study 44
Figure 17: Post Marketing Clinical Research, Post Marketing Surveillance of Orphan Drugs – Erbitux Case Study 48
Figure 18: Post Marketing Clinical Research, Post Marketing Surveillance of Vaccines – Rotateq Case Study 49
Figure 19: Post Marketing Clinical Research, Drug Safety Monitoring of Anti-HIV Treatment – Hivid Case Study 51
Figure 20: Post Marketing Clinical Research, Monoclonal Antibodies – Mylotarg Case Study 52
Figure 21: Post Marketing Clinical Research, Monoclonal Antibodies – Rituxan Case Study 53
Figure 22: Post Marketing Clinical Research, Functions of UMC 56
Figure 23: Post Marketing Clinical Research, Important Titles Under FDAAA, 2007 58
Figure 24: Post Marketing Clinical Research, Adverse Event Reports in the US (‘000), 2000-2009 61
Figure 25: Post Marketing Clinical Research, Post Marketing Surveillance System, Japan 70
Figure 26: Post Marketing Clinical Research, Limitations of Outsourcing 77